業績

ページタイトル画像

英文業績 2021-2025年

  • 2024年
  • 2023年
  • 2022年
  • 2021年

2024年（Total Impact Factor 389.3）総説3件　原書・短報74件

総説

  1. Dharmadasa T, Pavey N, Tu S, Menon P, Huynh W, Mahoney CJ, Timmins HC, Higashihara M, van den Bos M, Shibuya K, Kuwabara S, Grosskreutz J, Kiernan MC, Vucic S. Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter. Clin Neurophysiol. 2024 Jul:163:68-89 IF 3.6
  2. Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H, Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T, Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C, Watanabe M, Fujihara K. Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan Multiple sclerosis and related disorders 2024 Oct:90:105829 IF 2.9
  3. Uzawa A, Oertel FC, Mori M, Paul F, Kuwabara S. NMOSD and MOGAD: an evolving disease spectrum Nat Rev Neurol. 2024 Oct;20(10):602-619 IF 33.1

原著・短報

 

  1. Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial The Lancet. Neurology 2024 Oct;23(10):1013-1024. IF 45.5
  2. Amagai R, Otomo R, Yoshioka S, Nagano H, Hashimoto N, Sakakibara R, Tanaka T, Okado-Matsumoto A. C-terminal truncation is a prominent post-translational modification of human erythrocyte α-synuclein. J Biochem. 2024 May 31;175(6):649-658. IF 1.7
  3. Aotsuka Y, Misawa S, Suichi T, Shibuya K, Nakamura K, Kano H, Otani R, Morooka M, Ogushi M, Nagashima K, Sato Y, Kuriyama N, Kuwabara S. Prevalence and clinical profiles of anti-myelin-associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients. Eur J Neurol. 2024 May;31(5):e16249. IF 3.9
  4. Aotsuka Y, Misawa S, Suichi T, Shibuya K, Nakamura K, Kano H, Otani R, Morooka M, Ogushi M, Nagashima K, Sato Y, Kuriyama N, Kuwabara S. Prevalence, Clinical Profiles, and Prognosis of CIDP in Japanese Nationwide Survey: Analyses of 1,257 Diagnosis-Confirmed Patients. Neurology. 2024 Mar 26;102(6):e209130. IF 8.5
  5. Aotsuka Y, Misawa S, Suichi T, Shibuya K, Nakamura K, Kano H, Otani R, Morooka M, Ogushi M, Nagashima K, Sato Y, Kuriyama N, Kuwabara S. Multifocal motor neuropathy in Japan: A nationwide survey on prevalence, clinical profiles, and treatment Muscle & nerve 2024 Nov;70(5):1027-1033. IF 3.1
  6. "Arends S, Drenthen J, de Koning L, van den Bergh P, Hadden RDM, Kuwabara S, Reisin RC, Shahrizaila N, Ajroud-Driss S, Antonini G, Attarian S, Balducci C, Bertorini T, Brannagan TH, Cavaletti G, Chao CC, Chavada G, Dillmann KU, Dimachkie MM, Galassi G, Gutiérrez-Gutiérrez G, Harbo T, Islam B, Islam Z, Katzberg H, Kusunoki S, Manganelli F, Miller JAL, Pardo J, Pereon Y, Rajabally YA, Sindrup S, Stettner M, Uncini A, Verhamme C, Vytopil M, Waheed W, Jacobs BC, Cornblath DR; IGOS Consortium. Electrodiagnostic subtyping in Guillain-Barré syndrome patients in the International Guillain-Barré Outcome Study European journal of neurology 2024 Sep;31(9):e16335 IF 3.9
  7. Carlos AF, Koga S, Graff-Radford NR, Baker MC, Rademakers R, Ross OA, Dickson DW, Josephs KA,  Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss. Neuropathology. 2024 Apr;44(2):115-125. IF 1.2
  8. 659. Chikada A, Orimo K, Mitsui J, Matsukawa T, Ishiura H, Toda T, Mizusawa H, Takahashi Y, Katsuno M, Hara K, Onodera O, Ishihara T, Tada M, Kuwabara S, Sugiyama A, Yamanaka Y, Takahashi R, Sawamoto S, Sakato Y, Ishimoto T, Hanajima R, Watanabe Y, Takigawa H, Adachi T, Abe K, Yamashita T, Takashima H, Higashi K, Kira J, Yabe I, Matsushima M, Ogata K, Ishikawa K, Nishida Y, Ishiguro T, Ozaki K, Nagata T, Tsuji S. The Japan MSA registry: A multicenter cohort study of multiple system atrophy. Neurology and Clinical Neuroscience. 2024;12:271–277. IF 0.4
  9. Du W, Jin X, Harris JC, Brunetti A, Johnson E, Leung O, Li X, Walle S, Yu Q, Zhou X, Bian F, McKenzie K, Kanathanavanich M, Ozcelik Y, El-Sharkawy F, Koga S. Large language models in pathology: A comparative study of ChatGPT and Bard with pathology trainees on multiple-choice questions Ann Diagn Pathol. 2024 Dec;73:152392 IF 1.4
  10. Eki A, Sugiyama A, Shibuya K, Nakagawa Y, Ishige T, Suichi T, Otani R, Kuwabara S. Split hand and minipolymyoclonus in spinocerebellar ataxia type 3: a case report BMC neurology 2024 Nov 9;24(1):434.  IF 2.2
  11. Endo H, Ono M, Takado Y, Matsuoka K, Takahashi M, Tagai K, Kataoka Y, Hirata K, Takahata K, Seki C, Kokubo N, Fujinaga M, Mori W, Nagai Y, Mimura K, Kumata K, Kikuchi T, Shimozawa A, Mishra SK, Yamaguchi Y, Shimizu H, Kakita A, Takuwa H, Shinotoh H, Shimada H, Kimura Y, Ichise M, Suhara T, Minamimoto T, Sahara N, Kawamura K, Zhang MR, Hasegawa M, Higuchi M. Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases. Neuron. 2024 May 27:S0896-6273(24)00332-5. IF 15.0
  12. Fujiwara A, Horii W, Sano J, Kodama T, Kato A, Shibuya K, Saitoh T. Invasion of Chicken Anemia Virus in Specific-Pathogen-Free Chicken Flocks and Its Successful Elimination from the Colony Vet Sci. 2024 Jul 22;11(7):329. IF 2.3
  13. González-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia-Pavia P, Chapman D, Gupta P, Glass O, Amass L; THAOS investigators.(Misawa S.) Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey. Cardiol Ther. 2024 Mar;13(1):117-135. IF 2.7
  14. Handa H, Sugiyama A, Kaname T, Shigemoto Y, Sato N, Hirano S, Nakagawa Y, Uzawa A, Aotsuka A, Kuwabara S. Frontal deficits and atrophy in a patient with familial encephalopathy with neuroserpin inclusion bodies detected by single-case voxel-based morphometry: a case report. BMC Neurol. 2024 Jan 2;24(1):9. IF 2.2
  15. Handa H, Uzawa A, Mori M, Yasuda M, Onishi Y, Akamine H, Ogaya E, Niibe Y, Yokota H, Kuwabara S. Effects of Denosumab and Bisphosphonates on Glucocorticoid-induced Osteoporosis in Patients with Neuroimmunological Disorders Internal medicine 2025 Feb 15;64(4):543-549. IF 1.1
  16. Handa H, Sugiyama A, Kubosawa H, Nakagawa Y, Kishida D, Uzawa A, Aotsuka A, Kuwabara S. A patient with P369S/R408Q variants in the MEFV gene presented with clinical features of Kikuchi disease and Mollaret meningitis, successfully treated with colchicine BMC Neurol. 2024 Nov 14;24(1):446. IF 2.2
  17. Hatano T, Sengoku R, Nagayama H, Yanagisawa N, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Kaida K, Ihara R, Kanemaru K, Kano O. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study. Neurol Ther. 2024 Apr;13(2):323-338. IF 4.8
  18. Hara T, Amagai R, Sakakibara R, Okado-Matsumoto A. Supercomplex formation of mitochondrial respiratory chain complexes in leukocytes from patients with neurodegenerative diseases. J Biochem.  2024 Mar 4;175(3):289-298. IF 1.7
  19. Higashihara M, Pavey N, Menon P, van den Bos M, Shibuya K, Kuwabara S, Kiernan MC, Koinuma M, Vucic S. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study. Eur J Neurol.  2024 Mar 20:e16281.  IF 3.9
  20. Himuro K, Uzawa A, Kawaguchi N, Kanai T, Isono S, Kuwabara S. Quantitative assessment of dysphagia in myasthenia gravis Internal medicine 2024 Oct 18.  IF 1.1
  21. Hiraga A. Hand knob sign in Marchiafava-Bignami disease and Wernicke's encephalopathy. Neurol Sci. 2024 Jun;45(6):2903-2904.  IF 2.4
  22. Hiraga A, Kojima K. Severe Headache in a Man With a History of Migraine: The Importance of 'Peripheral Vision'. Am J Med. 2024 Feb;137(2):e26-e28. IF 5.3
  23. Hiraga A, Kojima K, Kuwabara S. Typical and atypical MRI abnormalities in Wernicke's encephalopathy: Correlation with blood vitamin B1 levels. J Neurol Sci.  2024 Jun 15;461:123045. IF 3.2
  24. Hiraga A, Kojima K, Suzuki M, Kuwabara S. Isolated contralateral spinothalamic sensory loss below thoracic level due to lateral medullary infarction. Acta Neurol Belg. 2024 Feb;124(1):279-281. IF 2.1
  25. Hiraga A, Mori M, Aoyama S. A Young Man With Paraparesis After Influenza Virus Infection Ann Emerg Med. 2024 Dec;84(6):690-691. IF 5.0
  26. Hirata K, Matsuoka K, Tagai K, Endo H, Tatebe H, Ono M, Kokubo N, Kataoka Y, Oyama A, Shinotoh H, Takahata K, Obata T, Dehghani M, Near J, Kawamura K, Zhang MR, Shimada H, Shimizu H, Kakita A, Yokota T, Tokuda T, Higuchi M, Takado Y. In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy. Ann Neurol. 2024 Aug;96(2):247-261. IF 7.7
  27. Ikeda A, Meng H, Taniguchi D, Mio M, Funayama M, Nishioka K, Yoshida M, Li Y, Yoshino H, Inoshita T, Shiba-Fukushima K, Okubo Y, Sakurai T, Amo T, Aiba I, Saito Y, Saito Y, Murayama S, Atsuta N, Nakamura R, Tohnai G, Izumi Y, Morita M, Tamura A, Kano O, Oda M, Kuwabara S, Yamashita T, Sone J, Kaji R, Sobue G, Imai Y, Hattori N. CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasis PNAS nexus 2024 Jul 30;3(8):pgae319 IF 3.8
  28. Imajoh M, Mori M, Shimizu T, Koizumi Y, Kobayashi Y, Kawahara M, Daibata M. Complete genome sequence of Edwardsiella tarda strain GBS0709 isolated from a Japanese patient with the acute motor axonal neuropathy subtype of Guillain-Barré syndrome Microbiol Resour Announc. 2024 Sep 10;13(9):e0045624. IF 0.6
  29. Ishihara T, Koyama A, Atsuta N, Tada M, Toyoda S, Kashiwagi K, Hirokawa S, Hatano Y, Yokoseki A, Nakamura R, Tohnai G, Izumi Y, Kaji R, Morita M, Tamura A, Kano O, Aoki M, Kuwabara S, Kakita A, Sobue G, Onodera O. SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan BMC Med Genomics. 2024 Nov 6;17(1):263. IF 2
  30. Ishii A, Tsukamoto S, Mimura N, Miyamoto-Nagai Y, Isshiki Y, Matsui S, Nakao S, Shibamiya A, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Takeda Y, Suichi T, Misawa S, Ohwada C, Yokote K, Kuwabara S, Nakaseko C, Takamatsu H, Sakaida E. Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry. Sci Rep. 2024 May 6;14(1):10362. IF 3.9
  31. Ishikawa A, Takeda T, Kokubun S, Saito Y, Isose S, Ito K, Arai K, Sugiyama A, Kuwabara S, Honda K. Putaminal hypointensity on T2-weighted MRI mimicking multiple system atrophy in amyotrophic lateral sclerosis: An autopsy case report. J Neurol Sci. 2024 May 15;460:123025. IF 3.2
  32. Ito M, Sugiyama A, Higuchi Y, Takashima H, Takahashi Y, Mizusawa H, Kuwabara S Writer's Cramps as an Initial Symptom of Spinocerebellar Ataxia Type 14 Internal medicine 2024 Aug 1;63(15):2183-2186. IF 1.1
  33. Kinoshita M, Oyanagi K, Matsushima A, Kondo Y, Hirano S, Ishizawa K, Ishihara K, Terada S, Inoue T, Yazawa I, Washimi Y, Yamada M, Nakayama J, Mitsuyama Y, Ikeda SI, Sekijima Y. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Estimation of pathological lesion stage from brain images. J Neurol Sci.  2024 Jun 15;461:123027. IF 3.2
  34. Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, Kakita A, Akatsu H, Ozaki K, Niida S, Kuwano R, Iwatsubo T, Nakaya A, Ikeuchi T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative.(Shimada H.) Polygenic effects on the risk of Alzheimer's disease in the Japanese population. Alzheimers Res Ther.  2024 Feb 27;16(1):45. IF 7.6
  35. Koga S. The double-edged nature of ChatGPT in self-diagnosis. Wien Klin Wochenschr. 2024 Apr;136(7-8):243-244. IF 2.1
  36. Koga S,  Evaluating ChatGPT in pathology: towards multimodal AI in medical imaging. J Clin Pathol.  2024 Mar 14:jcp-2024-209483. IF 2.0
  37. Koga S, Du W. ChatGPT's limited accuracy in generating anatomical images for medical education. Skeletal Radiol. 2024 Aug;53(8):1595-1596. IF 2.2
  38. Koga S, Du W. Challenges of Integrating Chatbot Use in Ophthalmology Diagnostics JAMA Ophthalmol 2024 Sep 1;142(9):883-884. IF 9.2
  39. Koga S, Du W. Integrating AI in medicine: Lessons from Chat-GPT's limitations in medical imaging. Dig Liver Dis. 2024 Jun;56(6):1114-1115. IF 3.8
  40. Koga S, Du W, Ono D. Response to "Can ChatGPT Vision diagnose melanoma? An exploratory diagnostic accuracy study.". J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00671-6. IF 11.8
  41. Koga S, Gates JC, Peters SM, Cooper K. Intraosseous mandibular clear cell odontogenic carcinoma with predominant small round blue cells: a potential diagnostic pitfall Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Dec;138(6):e120-e124. IF 1.9
  42. Koga S, Martin NB, Dickson DW. Evaluating the performance of large language models: ChatGPT and Google Bard in generating differential diagnoses in clinicopathological conferences of neurodegenerative disorders. Brain Pathol. 2024 May;34(3):e13207. IF 6.2
  43. Koga S, Du W, Ono D. Performance and limitations of customized ChatGPT in histopathologic diagnosis Ann Diagn Pathol. 2024 Dec;73:152362. IF 1.4
  44. Kanathanavanich M, Koga S, Stone SL, Roth J, Abdullaev Z, O'Rourke DM, Bagley S, Kurtz RM, Alonso-Basanta M, Aldape K, Nasrallah MP, Yang G. CTDSP2::GLI1 fusion in glioblastoma: A diagnostic challenge through tumor heterogeneity J Neuropathol Exp Neurol. 2024 Dec 1;83(12):1076-1080. IF 3.0
  45. Kubota M, Endo H, Takahata K, Tagai K, Suzuki H, Onaya M, Sano Y, Yamamoto Y, Kurose S, Matsuoka K, Seki C, Shinotoh H, Kawamura K, Zhang MR, Takado Y, Shimada H, Higuchi M. In vivo PET classification of tau pathologies in patients with frontotemporal dementia. Brain Commun. 2024 Mar 1;6(2):fcae075. IF 4.5
  46. Kuroiwa R, Shibuya K, Inagaki T, Nara T, Nemoto M, Doi Y, Yasuda M, Uzawa A, Shiko Y, Murata A, Yamanaka Y, Kuwabara S. Reliability and validity of cough peak flow measurements in myasthenia gravis. Neuromuscul Disord. 2024 Aug;41:29-34. IF 2.8
  47. Kuwabara S, Kusunoki S, Kuwahara M, Yamano Y, Nishida Y, Ishida H, Kasuya T, Kupperman E, Lin Q, Frick G, Misawa S. Efficacy and safety of eculizumab in Guillain-Barré syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial Journal of the peripheral nervous system : JPNS 2024 Sep;29(3):339-349 IF 3.2
  48. Matsuoka K, Hirata K, Kokubo N, Maeda T, Tagai K, Endo H, Takahata K, Shinotoh H, Ono M, Seki C, Tatebe H, Kawamura K, Zhang MR, Shimada H, Tokuda T, Higuchi M, Takado Y. Investigating neural dysfunction with abnormal protein deposition in Alzheimer's disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography. Neuroimage Clin. 2024;41:103560. IF 3.6
  49. Morino H, Kurashige T, Matsuda Y, Ono M, Sahara N, Miyasaka T, Soeda Y, Shimada H, Yamazaki Y, Takahashi T, Izumi Y, Ito H, Maruyama H, Higuchi M, Arihiro K, Suhara T, Takashima A, Kawakami H. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation. Mov Disord Clin Pract. 2024 Jun;11(6):720-727. IF 2.7
  50. Namba S, Yokota H, Mukai H, Hashiba J, Kogayo N, Nakao T, Sugiyama A, Ogaya E, Aotsuka Y, Kuwabara S, Uno T. Neurosarcoidosis with enlargement of the dorsal root ganglia: A case report. Radiol Case Rep. 2024 Feb 13;19(5):1718-1721.  IF ―
  51. Ono D, Dickson DW, Koga S. Evaluating the efficacy of few-shot learning for GPT-4Vision in neurodegenerative disease histopathology: A comparative analysis with convolutional neural network model Neuropathol Appl Neurobiol. 2024 Aug;50(4):e12997. IF 3.4
  52. Otani R, Shibuya K, Shimizu T, Kitaoji T, Noto YI, Bokuda K, Kimura H, Suichi T, Nakamura K, Kano H, Morooka M, Aotsuka Y, Ogushi M, Misawa S, Kuwabara S. Diagnostic utility of Gold Coast criteria for amyotrophic lateral sclerosis in Asia. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):264-270. IF 2.8
  53. Otani R, Shibuya K, Suzuki YI, Suichi T, Morooka M, Aotsuka Y, Ogushi M, Kuwabara S. Effects of motor cortical and peripheral axonal hyperexcitability on survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2024 Jul 15;95(8):730-736. IF 7.5
  54. Mitsui T, Sekido N, Masumori N, Haga N, Omae K, Saito M, Kubota Y, Sakakibara R, Yoshida M, Takahashi S. Prevalence and impact on daily life of lower urinary tract symptoms in Japan: Results of the 2023 Japan Community Health Survey (JaCS 2023). Int J Urol. 2024 Jul;31(7):747-754. IF 2.2
  55. Nishiyama M, Koreki A, Isose S, Takeda T, Ishikawa A, Kokubun S, Saito Y, Ito K, Arai K, Takahashi N, Motoda Y, Kuwabara S, Honda K. Factors associated with psychological distress in patients with amyotrophic lateral sclerosis: A retrospective medical records study. Journal of psychosomatic research 2024 Sep 3:187:111915. IF 3.3
  56. Sekiya H, Koga S, Murakami A, DeTure M, Ross OA, Uitti RJ, Cheshire WP, Wszolek ZK, Dickson DW. Frequency of Comorbid Pathologies and Their Clinical Impact in Multiple System Atrophy. Mov Disord. 2024 Feb;39(2):380-390. IF 7.6
  57. Sugimoto T, Suzuki S, Uzawa A, Yamawaki T, Masuda M, Minami N, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Konno S, Kimura T, Samukawa M, Ishizuchi K, Akamine H, Onishi Y, Yasuda M, Nagane Y, Maruyama H, Murai H, Utsugisawa K. Worsening of myasthenic symptoms associated with statins Journal of the neurological sciences 2024 Sep 15:464:123154. IF 3.2
  58. Suzuki M, Hirano S, Otte K, Schmitz-Hübsch T, Izumi M, Tamura M, Kuroiwa R, Sugiyama A, Mori M, Röhling M H, Brandt U A, Murata A, Paul F, Kuwabara S. Digital Motor Biomarkers of Cerebellar Ataxia Using an RGB-Depth Camera-Based Motion Analysis System. Cerebellum. 2024 Jun;23(3):1031-1041. IF 2.4
  59. Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S, Kubota T, Samukawa M, Ishizuchi K, Tokuyasu D, Handa H, Yasuda M, Kawaguchi N, Kimura T, Suzuki Y, Sugimoto T, Minami N, Takahashi MP, Murai H, Utsugisawa K. Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurol Clin Pract. 2024 Jun;14(3):e200276. IF 3.2
  60. Tang Z, Hirano S, Koizumi Y, Izumi M, Kitayama Y, Yamagishi K, Tamura M, Ishikawa A, Kashiwado K, Iimori T, Mukai H, Yokota H, Horikoshi T, Uno T, Kuwabara S. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies. J Alzheimers Dis. 2024;100(1):127-137. IF 3.1
  61. Takeda T, Koreki A, Kokubun S, Saito Y, Ishikawa A, Isose S, Ito K, Arai K, Kitagawa K, Kuwabara S, Honda K. Deep vein thrombosis and its risk factors in neurodegenerative diseases: A markedly higher incidence in Parkinson's disease. J Neurol Sci. 2024 Feb 15;457:122896. IF 3.2
  62. Tokuyasu D, Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S, Kubota T, Samukawa M, Sugimoto T, Ishizuchi K, Oyama M, Yasuda M, Akamine H, Onishi Y, Suzuki Y, Kawaguchi N, Minami N, Kimura T, Takahashi MP, Murai H, Utsugisawa K. Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Ann Clin Transl Neurol. 2024 May;11(5):1338-1346. IF 3.9
  63. Uzawa A, Mori M, Masuda H, Muto M, Ohtani R, Aoyama S, Matsushita K, Kuwabara S. Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler. 2024 Jul;30(8):977-982. IF 5.0
  64. Uzawa A, Mori M, Masuda H, Uchida T, Muto M, Ohtani R, Aoyama S, Kuwabara S. Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. J Neurol Neurosurg Psychiatry. 2024 Jun 17;95(7):626-629. IF 7.5
  65. Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K. Taste disorders and alopecia in myasthenia gravi. BMC Neurol. 2024 Apr 25;24(1):139. IF 2.2
  66. Uzawa A, Yasuda M, Akamine H, Onishi Y, Handa H, Ogaya E, Ozawa Y, Masuda H, Mori M, Kuwabara S. Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis. Scand J Immunol. 2024 May;99(5):e13360. IF 1.6
  67. Utsugisawa K, Deguchi K, Konno S, Masuda M, Minami N, Murai H, Suzuki S, Suzuki Y, Tsujino A, Uzawa A, Boroojerdi B, Borderie d l G, Brock M, Duda W B, Vanderkelen M, Howard F J. Efficacy and safety of zilucoplan in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the phase III randomized RAISE study. Clin Exp Neuroimmunol. 2024;15:45–54. IF ―
  68. Valentino RR, Scotton WJ, Roemer SF, Lashley T, Heckman MG, Shoai M, Martinez-Carrasco A, Tamvaka N, Walton RL, Baker MC, Macpherson HL, Real R, Soto-Beasley AI, Mok K, Revesz T, Christopher EA, DeTure M, Seeley WW, Lee EB, Frosch MP, Molina-Porcel L, Gefen T, Redding-Ochoa J, Ghetti B, Robinson AC, Kobylecki C, Rowe JB, Beach TG, Teich AF, Keith JL, Bodi I, Halliday GM, Gearing M, Arzberger T, Morris CM, White CL 3rd, Mechawar N, Boluda S, MacKenzie IR, McLean C, Cykowski MD, Wang SJ, Graff C, Nagra RM, Kovacs GG, Giaccone G, Neumann M, Ang LC, Carvalho A, Morris HR, Rademakers R, Hardy JA, Dickson DW, Rohrer JD, Ross OA; Pick's disease International Consortium. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study. Lancet Neurol. 2024 May;23(5):487-499. IF 45.5
  69. Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA, Heckman MG. Role of GBA variants in Lewy body disease neuropathology. Acta Neuropathol. 2024 Mar 12;147(1):54. IF 9.3
  70. Wang J, Sugiyama A, Yokota H, Hirano S, Yamamoto T, Yamanaka Y, Araki N, Ito S, Paul F, Kuwabara S. Differentiation between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle. Diagnostics (Basel). 2024 Jan 17;14(2):201. IF 3.3
  71. Watanabe M, Isobe N, Niino M, Nakashima I, Matsushita T, Sakai Y, Nakahara J, Kawachi I, Ochi H, Nakatsuji Y, Nakamura Y, Nakamura K, Sakata K, Matsui M, Kuwabara S, Kira JI Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Japan by the Fifth Nationwide Survey Neurology 2024 Nov 26;103(10):e209992. IF 8.5
  72. Yamamoto T, Sakakibara R, Uchiyama T, Kuwabara S. The examination of detrusor underactivity in multiple system atrophy Frontiers in neurology 2024 Sep 17:15:1460379 IF 2.8
  73. Yasuda M, Uzawa A, Onishi Y, Handa H, Akamine H, Ogaya E, Ozawa Y, Masuda H, Mori M, Kuwabara S. Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis Journal of neuroimmunology 2024 Nov 15;396:578455 IF 2.5
  74. Yoshitake M, Sugiyama A, Shimohata T, Araki N, Suzuki M, Shibuya K, Nagashima K, Hattori N, Kuwabara S. Delivering the diagnosis of multiple system atrophy: a multicenter survey on Japanese neurologists' perspectives. BMC Neurol. 2024 May 13;24(1):160. IF 2.2

2023年（Total Impact Factor 472.2）総説3件　原書・短報45件

総説

  1. Uzawa A, Utsugisawa K. Biological therapies for myasthenia gravis. Expert Opin Biol Ther. 2023 Mar;23(3):253-260. IF 3.6
  2. Murai H, Utsugisawa K, Motomura M, Imai T, Uzawa A, Suzuki S. The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome. Clin Exp Neuroimmunol. 2023;14(1):19–27. IF－
  3. Suzuki S, Masuda M, Uzawa A, Nagane Y, Konno S, Suzuki Y, Kubota T, Sugimoto T, Samukawa M, Watanabe G, Ishizuchi K, Akamine H, Onishi Y, Yoshimizu K, Uchi T, Amino I, Ueta Y, Minami N, Kawaguchi N, Kimura T, Takahashi M, Murai H, Utsugisawa K. Japan MG registry: Chronological surveys over 10 years. Clin Exp Neuroimmunol. 2023 Feb;14(1):5-12. IF－

原著・短報

  1. Akamine H, Uzawa A, Kojima Y, Ozawa Y, Yasuda M, Onishi Y, Kuwabara S. Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis. J Neuroimmunol. 2023 Feb 15;375:578014. IF 2.9
  2. Izumi M, Uzawa A, Aoki R, Suzuki M, Yoshizawa K, Suzuki Y, Kimura A, Shimohata T, Kuwabara S. Delayed Appearance of Brain Magnetic Resonance Imaging Abnormalities in a Patient with Glial Fibrillary Acidic Protein Astrocytopathy. Intern Med. 2023 Feb 1;62(3):465-468. IF 1.0
  3. Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Muto M, Ohtani R, Aoki R, et al. Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls. Sci Rep. 2023 Aug 3;13(1):12631. IF 3.8
  4. Masuda H, Mori M, Uzawa A, Uchida T, Muto M, Ohtani R, Aoki R, Kuwabara S. Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD. Sci Rep. 2023 Mar 2;13(1):3538. IF 3.8
  5. Misawa S, Denda T, Kodama S, Suzuki T, Naito Y, Kogawa T, Takada M, Suichi T, Shiosakai K, Kuwabara S; MiroCIP study group. Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study). BMC Cancer. 2023 Nov 11;23(1):1098. IF 3.4
  6. Murakami E, Uzawa A, Ozawa Y, Yasuda M, Onishi Y, Ozawa Y, Akamine H, Kawamoto M, et al. Effects of BL 23 (Shenshu) acupuncture on serum cytokine levels in healthy adults: A randomized double-blind sham-controlled phase 1 study. J Neuroimmunol. 2023 Sep 15;382:578165. IF 2.9
  7. Muroga Y, Sugiyama A, Mukai H, Hashiba J, Yokota H, Satoh K, Kitamoto T, Wang J, Ito S, Kuwabara S. Cerebral cortex swelling in V180I genetic Creutzfeldt-Jakob disease: comparative imaging study between sporadic and V180I genetic Creutzfeldt-Jakob disease in the early stage. Prion. 2023 Dec;17(1):105-110. IF 1.9
  8. Sugiyama A, Kojima K, Hirano S, Sone J, Kuwabara S. Unilateral Wing-Beating Tremor in Neuronal Intranuclear Inclusion Disease. Case Rep Neurol. 2023 Jun 5;15(1):126-130. IF 0.6
  9. Sugiyama A, Yokota H, Hirano S, Wang J, Ito S, Kuwabara S. Association between Cognitive Impairment and Hippocampal Subfield Volumes in Multiple System Atrophy. Parkinsons Dis. 2023 Mar 6;2023:8888255. IF 2.1
  10. Tamura M, Takeda T, Kitayama Y, Suichi T,  Shibuya T, Harada-Kagitani S, Kishimoto T, Kuwabara S, Hirano S. Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study. Front Neurol. 2023 Nov 14:14:1293732. IF 2.7
  11. Uzawa A, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kuwabara S. Minimal symptom expression achievement over time in generalized myasthenia gravis. Acta Neurol Belg. 2023 Jun;123(3):979-982. IF 2.0
  12. Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi M P, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):467-473. IF 8.8
  13. Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi M P, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K. Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. Neurotherapeutics. 2023 Mar;20(2):518-523. IF 5.6
  14. Yasuda M, Uzawa A, Ozawa Y, Onishi Y, Akamine H, Kuwabara S. Serum cytokine profiles in myasthenia gravis with anti-muscle-specific. J Neuroimmunol. 2023 Nov 7:385:578241. IF 2.9
  15. Yasuda M, Uzawa A, Ozawa Y, Onishi Y, Akamine H, Kuwabara S. Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies. J Neuroimmunol. 2023 Nov 15:384:578205. IF 2.9
  16. Al-Hakem H, Doets A Y, Stino A M, et al.(Kuwabara S.) Cerebrospinal Fluid Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome. Neurology. 2023 Jun 6;100(23):e2386-e2397. IF 8.4
  17. Bolborea M, Vercruysse P, Daria T, Reiners J C, Alami N O, Guillot S J, Dieterlé S, Sinniger J, Scekic-Zahirovic J, Londo A, Arcay H, Goy M A, de Tapia C N, Thal D R, Shibuya K, Otani R, Arai K, Kuwabara S, Ludolph A C, Roselli F, Yilmazer-Hanke D, Dupuis L. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis. Acta Neuropathol. 2023 Jun;145(6):773-791. IF 9.3
  18. Bril V, Drużdż A, Grosskreutz J, Habib A A, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski H J. ; MG0003 study team.(Uzawa A.) Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. Lancet Neurol. 2023 May;22(5):383-394. IF 46.0
  19. CoelhoT, Dispenzieri A, Grogan M, Conceição I, Waddington-Cruz M, V Kristen A, Wixner J, Diemberger I, Gonzalez-Moreno J , Maurer S M, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Cariou E, González-Duarte A, Glass O, Chapman D, Amass L; THAOS investigators.(Misawa S.) Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay. Amyloid. [Online ahead of print.] IF 5.2
  20. Fujii K, Shiohama T, Uchida T, Ikehara H, Fukuhara T, Sawada D, Aoyama H, Uchikawa H, Yoshii S, Arahata Y, Shimojo N, Misawa S, Kuwabara S. Nationwide survey of childhood Guillain-Barré syndrome, Fisher syndrome, and Bickerstaff brainstem encephalitis in Japan. Brain Dev. 2023 Jan;45(1):16-25. IF 1.5
  21. Hashiba J, Yokota H, Abe K, Sekiguchi Y, Ikeda S, Sugiyama A, Kuwabara S, Uno T. Ultrasound-based radiomic analysis of the peripheral nerves for differentiation between CIDP and POEMS syndrome. Acta Radiol. 2023 Sep;64(9):2627-2635. IF 1.1
  22. Hiraga A, Kojima K, Kuwabara S. Clinical features and recovery pattern of secondary hypokalaemic paralysis. J Neurol. 2023 Nov;270(11):5571-5577. IF 4.8
  23. Hiraga A, Kojima K, Kuwabara S. Isolated thumb palsy due to cortical infarction outside the 'hand knob'. Neurol Sci. 2023 Jul;44(7):2603-2604. IF 2.7
  24. Hiraga A, Kurumada K, Kojima K, Kuwabara S. Cerebral Vasculitis due to Invasive Disseminated Streptococcus intermedius Infection in an Immunocompetent Adult. Stroke. 2023 May;54(5):e211-e212. IF 7.9
  25. Hiraga A, Watabe Y, Kuwabara S. 'Dense Inverted Triangle Sign' in Cerebral Venous Thrombosis. Intern Med. 2023 Jul 15;62(14):2129-2131. IF 1.0
  26. Howard J F, Jr., Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski H J, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss M D, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda P W, Lowcock R, Vanderkelen M, Leite M I; RAISE Study Team. (Uzawa A.) Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Neurol. 2023 May;22(5):395-406. IF 46.6
  27. Kainuma  M, Kawakatsu S, Kim J, Ouma S, Iritani O, Yamashita K, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan. Front Pharmacol. 2023 Jun 12;14:1203349. IF 4.4
  28. Kinouchi T, Terada J, Sakao S, Koshikawa K, Sasaki T, Sugiyama A, Sato S, Sakuma N, Abe M, Shikano K, Hayama N, Shiko Y, Ozawa Y, Ikeda S, Suzuki T, Tatsumi K. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial. Respirology. 2023 Mar;28(3):273-280. IF 6.6
  29. Kuroiwa R, Tateishi Y, Oshima T, Shibuya K, Inagaki T, Murata A, Kuwabara S. Cardiovascular autonomic dysfunction induced by mechanical insufflation-exsufflation in Guillain-Barré syndrome. Respirol Case Rep. 2023 Apr 13;11(5):e01135. IF 0.8
  30. Luijten L W G, Doets A Y, Arends S, Dimachkie M M, Gorson K C, Islam B, Kolb N A, Kusunoki S, Papri N, Waheed W, Walgaard C, Yamagishi Y, Lingsma H, Jacobs B C, IGOS Consortium.(Kuwabara S.) Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2023 Apr;94(4):300-308. IF 8.8
  31. Matsui N, Tanaka K, Ishida M, Yamamoto Y, Matsubara Y, Saika R, Iizuka T, Nakamura K, Kuriyama N, Matsui M, Arisawa K, Nakamura Y, Kaji R, Kuwabara S, Izumi Y; Japanese SPS Study. Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey. Neurol Neuroimmunol Neuroinflamm. 2023 Sep 22;10(6):e200165. IF 8.3
  32. Mitsui J, Matsukawa T, Uemura Y, Kawahara T, Chikada A, Porto K J L, Naruse H, Tanaka M, Ishiura H, Toda T, Kuzuyama H, Hirano M, Wada I, Ga T, Moritoyo T, Takahashi Y, Mizusawa H, Ishikawa K, Yokota T, Kuwabara S, Sawamoto N, Takahashi R, Abe K, Ishihara T, Onodera O, Matsuse D, Yamasaki R, Kira J I, Katsuno M, Hanajima R, Ogata K, Takashima H, Matsushima M, Yabe I, Sasaki H, Tsuji S. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial. EClinicalMedicine. 2023 Apr 14;59:101920. IF 9.6
  33. Mori S, Suzuki S, Konishi T, Kawaguchi N, Kishi M, Kuwabara S, Ishizuchi K, Zhou H, Shibasaki F, Tsumoto H, Omura T, Miura Y, Mori S, Higashihara M, Murayama S, Shigemoto K. Proteolytic ectodomain shedding of muscle-specific tyrosine kinase in myasthenia gravis. Exp Neurol. 2023 Mar;361:114300. IF 4.6
  34. Morooka M, Hiraga A, Tanaka K, Yoshizaki S, Koide K, Kuwabara S. Two Cases of Encephalitis without Anti-N-methyl-D-aspartate Receptor Antibody Successfully Treated with Ovarian Teratoma Resection and Immunotherapy. Intern Med. 2023 Jun 15;62(12):1817-1820. IF 1.0
  35. Nakagawa Y, Sugiyama A, Hirano S, Ishige T, Kuwabara S. Isolated paravermal T2 high-intensity lesions in dentatorubral-pallidoluysian atrophy. J Neurol Sci. 2023 Aug 15;451:120717. IF 3.7
  36. Nakamura M, Ogawa R, Fujimori J, Uzawa A, Sato Y, Nagashima K, Kuriyama N, Kuwabara S, Nakashima I. Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey. Mult Scler. 2023 Apr;29(4-5):530-539. IF4.8
  37. Nakamura R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, Katsuno M, Hirakawa A, Izumi Y, Morita M, Hirayama T, Kano O, Kanai K, Hattori N, Taniguchi A, Suzuki N, Aoki M, Iwata I, Yabe I, Shibuya K, Kuwabara S, Oda M, Hashimoto R, Aiba I, Ishihara T, Onodera O, Yamashita T, Abe K, Mizoguchi K, Shimizu T, Ikeda Y, Yokota T, Hasegawa K, Tanaka F, Nakashima K, Kaji R, Niwa J I, Doyu M, Terao C, Ikegawa S, Fujimori K, Nakamura S, Ozawa F, Morimoto S, Onodera K, Ito T, Okada Y, Okano H, Sobue G. Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients. J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):816-824. IF 8.8
  38. Niino M, Fukumoto S, Okuno T, Sanjo N, Fukaura H, Mori M, Ohashi T, Takeuchi H, Shimizu Y, Fujimori J, Kawachi I, Kira J I, Takahashi E, Miyazaki Y, Mifune N. Health-related quality of life in Japanese patients with multiple sclerosis. J Neurol. 2023 Feb;270(2):1011-1018. IF 4.8
  39. Oide S, Okubo R, Mitsuhashi T, Fukai K, Masuda H, Yamada Y, Yoshioka T. Clinical gynaecological perspectives to improve validity in clinical research: comment on the article by Chiuve et al. J Epidemiol Community Health. 2023 Mar;77(3):204. IF 4.9
  40. Ozawa Y, Uzawa A, Onishi Y, Yasuda M, Kojima Y, Kuwabara S. Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies. Muscle Nerve. 2023 Nov;68(5):798-804. IF 2.8
  41. Paul F, Marignier R, Palace J, Arrambide G, Asgari N, Bennett J L, Cree B A C, De Sèze J, Fujihara K, Kim H J, Hornby R, Huda S, Kissani N, Kleiter I, Kuwabara S, Lana-Peixoto M, Law L, Leite M I, Pandit L, Pittock S J, Quan C, Ramanathan S, Rotstein D, Saiz A, Sato D K, Vaknin-Dembinsky A. International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab. Neurol Neuroimmunol Neuroinflamm. 2023 May 31;10(4):e200124. IF 8.3
  42. Suzuki Y I, Kobayashi M, Kuwabara S. Spinal Arachnoid Web Probably Associated with Systemic Inflammation. Intern Med. 2023 Jul 1;62(13):2025-2026. IF 1.0
  43. Yamamoto T, Sakakibara R, Uchiyama T, Kuwabara S. Decreased bladder contraction interval induced by periaqueductal grey stimulation is reversed by subthalamic stimulation in a Parkinson's disease model rat. IBRO Neurosci Rep. 2023 Oct 17:15:293-303. IF 2.0
  44. Yamamoto T, Yamanaka Y, Hirano S, Higuchi Y, Kuwabara S. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation. Front Neurol. 2023 Jan 6;13:1042033. IF 2.7
  45. Yokouchi H, Nagasato D, Mitamura Y, Egawa M, Tabuchi H, Misawa S, Kuwabara S, Baba T. Alterations in choroidal vascular structures due to serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Sci Rep. 2023 Jun 30;13(1):10650. IF 3.8

2022年（Total Impact Factor 472.5）総説5件　原書・短報55件

総説

  1. Kuwabara S, Suichi T. Validation of the 2021 EAN/PNS diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2022 Dec;93(12):1237-1238. IF 11.1
  2. Shibuya K, Otani R, Suzuki Y I, Kuwabara S, Kiernan M C. Neuronal Hyperexcitability and Free Radical Toxicity in Amyotrophic Lateral Sclerosis: Established and Future Targets. Pharmaceuticals (Basel). 2022 Mar 31;15(4):433. IF 4.6
  3. Sugiyama A, Kuwabara S. Microstructural changes in the normal appearance cerebral cortex of multiple sclerosis detected by an advanced diffusion MRI technique. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):572. IF 11.1
  4. Suzuki S, Uzawa A, Murai H. Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective. Expert Rev Clin Immunol. 2022 Dec;18(12):1207-1215. IF 4.4
  5. Yamanaka Y, Araki N, Kuwabara S. Neurodegenerative disorders affecting the autonomic nervous system: Pure autonomic failure and multiple system atrophy. Neurology and Clinical Neuroscience. 2022;10(3):115-118. IF－

原著・短報

  1. Hirano S, Kojima A, Nakayama Y, Takeda T, Kishimoto T, Takahashi T, Kuwabara S, Mori M. A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study. BMC Neurol. 2022 Dec 15;22(1):483. IF 2.6
  2. Koide K, Sugiyama A, Yokota H, Mukai H, Wang J, Nakamura K, Misawa S, Ito S, Kuwabara S. Nerve Hypertrophy and Altered Diffusion in Anti-Myelin-Associated Glycoprotein Neuropathy Detected by Brachial Plexus Magnetic Resonance Neurography. Eur Neurol. 2022;85(2):95-103. IF 2.4
  3. Kojima Y, Uzawa A, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kawaguchi N, Himuro K, Noto Y I, Mizuno T, Kuwabara S. Serum pentraxin 3 concentration correlates with disease severity in patients with myasthenia gravis. Clin Neurol Neurosurg. 2022 Sep;220:107371. IF 1.9
  4. Kojima Y, Shibuya K, Uzawa A, Kano H, Nakamura K, Yasuda M, Suzuki YI, Tsuneyama A, Suichi T, Ozawa Y, Misawa S, Noto Y, Mizuno T, Kuwabara S. Decreased initial compound muscle action potential amplitudes in myasthenia gravis. Neurology and Clinical Neuroscience. 2022；10(5):245-251. IF 0.4
  5. Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Muto M, Ohtani R, Aoki R, Kuwabara S. Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):32-40. IF 11.1
  6. Masuda H, Mori M, Yokouchi H, Uzawa A, Uchida T, Muto M, Ohtani R, Aoki R, Yamamoto S, Kuwabara S. Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders. J Neurol. 2022 Apr;269(4):1996-2003. IF 6.0
  7. Osawa K, Sugiyama A, Uzawa A, Hirano S, Yamamoto T, Nezu M, Araki N, Kano H, Kuwabara S. Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19. Intern Med. 2022 Apr 1;61(7):1071-1076. IF 1.2
  8. Shibuya K, Tsuneyama A, Misawa S, Suzuki Y I, Suichi T, Kojima Y, Nakamura K, Kano H, Ohtani R, Aotsuka Y, Morooka M, Prado M, Kuwabara S. Different patterns of sensory nerve involvement in chronic inflammatory demyelinating polyneuropathy subtypes. Muscle Nerve. 2022 Aug;66(2):131-135. IF 3.4
  9. Sugiyama A, Nishigori C, Tsujimoto M, Togawa Y, Kuwabara S. Clinical Reasoning: A 60-Year-Old Man With Ataxia, Chorea, and Mild Cognitive Impairment. Neurology. 2022 Oct 4;99(14):618-624. IF 10.1
  10. Sugiyama A, Sone J, Kuwabara S. Teaching NeuroImages: Paravermal Lesions in Neuronal Intranuclear Inclusion Disease. Neurology. 2022 Sep 13;99(11):484-485. IF 10.1
  11. Sugiyama A, Tamiya A, Yokota H, Mukai H, Otani R, Kuwabara S. Frontotemporal Brain Sagging Syndrome as a Treatable Cause Mimicking Frontotemporal Dementia: A Case Report. Case Rep Neurol. 2022 Feb 15;14(1):82-87. IF 0.7
  12. Sugiyama A, Terada J, Shionoya Y, Hirano S, Yamamoto T, Yamanaka Y, Araki N, Koshikawa K, Kasai H, Ikeda S, Wang J, Koide K, Ito S, Kuwabara S. Sleep-related hypoventilation and hypercapnia in multiple system atrophy detected by polysomnography with transcutaneous carbon dioxide monitoring. Sleep Breath. 2022 Dec;26(4):1779-1789. IF 2.5
  13. Suichi T, Misawa S, Sekiguchi Y, Shibuya K, Nakamura K, Kano H, Aotsuka Y, Otani R, Morooka M, Tsukamoto S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Kuwabara S. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. Intern Med. 2022;61(17):2567-2572. IF 1.2
  14. Suzuki Y, Sugiyama A, Muto M, Satoh K, Kitamoto T, Kuwabara S. Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage. Cureus. 2022 Mar 21;14(3):e23374. IF 1.2
  15. Tamura M, Uzawa A, Kitayama Y, Habu Y, Kuwabara S. Multiple Cerebral Infarctions Complicating Deep Vein Thrombosis Associated With Uterine Adenomyosis: A Case Report and Literature Review. Cureus. 2022 Aug 16;14(8):e28061. IF 1.2
  16. Uzawa A, Mori M, Iwai Y, Masuda H, Kuwabara S. Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment. Intern Med. 2022 Sep 15;61(18):2785-2787. IF 1.2
  17. Wang J, Sugiyama A, Yokota H, Hirano S, Cooper G, Mukai H, Ohira K, Koide K, Ito S, Finke C, Brandt A U, Paul F, Kuwabara S. Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: A preliminary study. PLoS One. 2022 Apr 15;17(4):e0267024. IF 3.7
  18. Yasuda M, Sugiyama A, Hokkoku H, Suichi T, Ito K, Satoh K, Kitamoto T, Kuwabara S. Propagation of diffusion-weighted MRI abnormalities in the preclinical stage of sporadic Creutzfeldt-Jakob disease. Neurology. 2022 Oct 18;99(16):699-702. IF 10.1
  19. Yasuda M, Uzawa A, Ozawa Y, Kojima Y, Onishi Y, Akamine H, Kuwabara S. Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis. Scand J Immunol. 2022 Feb;95(2):e13122. IF 3.7
  20. Yasuda M, Yamanaka Y, Kano H, Araki N, Ishikawa H, Ikeda J I, Kuwabara S. Recurrent Cerebral Infarcts Associated with Uterine Adenomyosis: Successful Prevention by Surgical Removal. Intern Med. 2022 Mar 1;61(5):735-738. IF 1.2
  21. Almansour A, Ishiura H, Mitsui J, Matsukawa T, Kawabe M Matsukawa, Shimizu H, Sugiyama A, Toda T, Tsuji S. Frequency of FMR1 Premutation Alleles in Patients with Undiagnosed Cerebellar Ataxia and Multiple System Atrophy in the Japanese Population. Cerebellum. 2022 Dec;21(6):954-962. IF 3.5
  22. Arends S, Drenthen J, van den Bergh P, Franssen H, Hadden R D M, Islam B, Kuwabara S, Reisin R C, Shahrizaila N, Amino H, Antonini G, Attarian S, Balducci C, Barroso F, Bertorini T, Binda D, Brannagan T H, Buermann J, Casasnovas C, Cavaletti G, Chao C C, Dimachkie M M, Fulgenzi E A, Galassi G, Gutiérrez Gutiérrez G, Harbo T, Hartung H P, Hsieh S T, Kiers L, Lehmann H C, Manganelli F, Marfia G A, Mataluni G, Pardo J, Péréon Y, Rajabally Y A, Santoro L, Sekiguchi Y, Stein B, Stettner M, Uncini A, Verboon C, Verhamme C, Vytopil M, Waheed W, Wang M, Zivkovic S, Jacobs B C, Cornblath D R. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. Clin Neurophysiol. 2022 Jan 13;S1388-2457(22)00011-6. IF4.7
  23. Doets A Y, Lingsma H F, Walgaard C, et al.(Kuwabara S.) Predicting Outcome in Guillain-Barre Syndrome: International Validation of the Modified Erasmus GBS Outcome Score. Neurology. 2022 Feb 1;98(5):e518-e532. IF 10.1
  24. Doets A Y, Walgaard C, Lingsma H F, Islam B, Papri N, Yamagishi Y, Kusunoki S, Dimachkie M M, Waheed W, Kolb N, Gorson K C Jacobs B C. IGOS Consortium(Kuwabara S) International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score. Ann Neurol. 2022 Apr;91(4):521-531. IF 11.2
  25. Fukushima W, Hara M, Kitamura Y, Shibata M, Ugawa Y, Hirata K, Oka A, Miyamoto S, Kusunoki S, Kuwabara S, Hashimoto S, Sobue T. A nationwide epidemiological survey of adolescent patients with diverse symptoms similar to those following human papillomavirus vaccination: background prevalence and incidence for considering vaccine safety in Japan. J Epidemiol. 2022 Jan 5;32(1):34-43. IF 4.7
  26. Hasegawa T, Seo T, Kubota Y, Sudo T, Yokota K, Miyazaki N, Muranaka A, Hirano S, Yamauchi A, Nagashima K, Iyo M, Sakai I. Reliability and validity of the Japanese version of the 4A's Test for delirium screening in the elderly patient. Asian J Psychiatr. 2022 Jan;67:102918. IF 9.5
  27. Hatano T, Kano O, Sengoku R, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa M K, Terashi H, Kimura K, Tashiro J, Hirano S, Murakami H, Joki H, Uchiyama T, Shimura H, Ogaki K, Fukae J, Tsuboi Y, Takahashi K, Yamamoto T, Yanagisawa N, Nagayama H. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study. BMC Neurol. 2022 Mar 3;22(1):71. IF 2.6
  28. Hiraga A, Kojima K, Kitayama Y, Kiuchi Y, Kuwabara S. Sixth nerve palsy without other objective neurological deficits due to a small pontine infarction. Acta Neurol Belg. 2022 Jun;122(3):821-822. IF 2.7
  29. Hiraga A, Kojima K, Kuwabara S. Subacute combined degeneration of the spinal cord presenting with a longitudinally extensive spinal lesion with anterior funiculus involvement. Acta Neurol Belg. 2022 Aug;122(4):1099-1101. IF 2.7
  30. Hiraga A, Kuwabara S. Isolated spinothalamic sensory impairment of the contralateral lower limb due to lateral medullary infarction. Neurol Sci. 2022 Jan;43(1):725-726. IF 3.3
  31. Hiraga A, Kuwabara S. Ischemic Stroke Due to Metastatic Cervical Bone Tumor: The Importance of 'Peripheral Vision'. Am J Med. 2022 Mar 17;S0002-9343(22)00197-8. IF 5.9
  32. Hiraga A, Muto M, Kuwabara S. Loss of Taste as an Initial Symptom of a "Facial Diplegia and Paresthesia" Variant of Guillain-Barré Syndrome. Intern Med. 2022 Oct 1;61(19):2957-2959. IF 1.2
  33. Isshiki Y, Oshima M, Mimura N, Kayamori K, Miyamoto-Nagai Y, Seki M, Nakajima-Takagi Y, Kanamori T, Iwamoto E, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Misawa S, Ikeda J I, Sanada M, Kuwabara S, Suzuki Y, Sakaida E, Nakaseko C, Iwama A. Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis. JCI Insight. 2022 Oct 24;7(20):e151482. IF 8.0
  34. Ito M, Hiwasa T, Yajima S, Suzuki T, Oshima Y, Nanami T, Sumazaki M, Shiratori F, Li S Y, Iwadate Y, Sugimoto K, Mori M, Kuwabara S, Takizawa H, Shimada H. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma. Esophagus. 2022 Oct;19(4):617-625. IF 2.4
  35. Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita K I, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y. An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease. Front Pharmacol. 2022 Oct 14;13:991982. IF 5.6
  36. Kojima K, Hirano S, Kimura Y, Seki C, Ikoma Y, Takahata K, Ito T, Yokokawa K, Hashimoto H, Kawamura K, Zhang M R, Ito H, Higuchi M, Kuwabara S, Suhara T, Yamada M. Brain 5-HT(2A) receptor binding and its neural network related to behavioral inhibition system. Brain Imaging Behav. 2022 Jun;16(3):1337-1348. IF 3.2
  37. Leonhard S E, van der Eijk A A, Andersen H, et al.(Kuwabara S.) An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort. Neurology. 2022 Sep 20;99(12):e1299-e1313. IF 10.1
  38. Miyatake S, Koshimizu E, Fujita A, Doi H, Okubo M, Wada T, Hamanaka K, Ueda N, Kishida H, Minase G, Matsuno A, Kodaira M, Ogata K, Kato R, Sugiyama A, Sasaki A, Miyama T, Satoh M, Uchiyama Y, Tsuchida N, Hamanoue H, Misawa K, Hayasaka K, Sekijima Y, Adachi H, Yoshida K, Tanaka F, Mizuguchi T, Matsumoto N. Rapid and comprehensive diagnostic method for repeat expansion diseases using nanopore sequencing. NPJ Genom Med. 2022 Oct 26;7(1):62. IF 5.3
  39. Nakano Y, Hirano S, Kojima K, Li H, Sakurai T, Suzuki M, Tai H, Furukawa S, Sugiyama A, Yamanaka Y, Yamamoto T, Iimori T, Yokota H, Mukai H, Horikoshi T, Uno T, Kuwabara S. Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders. Mov Disord. 2022 Jun;37(6):1235-1244. IF 8.6
  40. Nakano Y, Shimada H, Shinotoh H, Hirano S, Tagai K, Sano Y, Yamamoto Y, Endo H, Matsuoka K, Takahata K, Kubota M, Takado Y, Kimura Y, Ichise M, Ono M, Sahara N, Kawamura K, Zhang M R, Kuwabara S, Suhara T, Higuchi M. PET-based classification of corticobasal syndrome. Parkinsonism Relat Disord. 2022 Apr 25;98:92-98. IF 4.1
  41. Niino M, Fukumoto S, Okuno T, Sanjo N, Fukaura H, Mori M, Ohashi T, Takeuchi H, Shimizu Y, Fujimori J, Kawachi I, Kira J I, Takahashi E, Miyazaki Y, Mifune N. Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan;57:103427. IF 4.0
  42. Oda F, Uzawa A, Ozawa Y, Yasuda M, Kuwabara S. Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy. J Neuroimmunol. 2022 Apr 15;365:577833. IF 3.3
  43. Ohira K, Yokota H, Hirano S, Nishimura M, Mukai H, Horikoshi T, Sawai S, Yamanaka Y, Yamamoto T, Kakeda S, Kuwabara S, Tanaka T, Uno T. DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson's Disease: Voxel-Based Morphometry. Parkinsons Dis. 2022 Mar 28;2022:8649195. IF 3.2
  44. Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R, Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for A L S C. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2022 Jun 1;79(6):575-583. IF 29.0
  45. Rohling H M, Althoff P, Arsenova R, Drebinger D, Gigengack N, Chorschew A, Kroneberg D, Ronnefarth M, Ellermeyer T, Rosenkranz S C, Heesen C, Behnia B, Hirano S, Kuwabara S, Paul F, Brandt A U, Schmitz-Hubsch T. Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study. JMIR Hum Factors. 2022 Apr 1;9(2):e26825. IF 2.7
  46. Shigemoto Y, Matsuda H, Kimura Y, Chiba E, Ohnishi M, Nakaya M, Maikusa N, Ogawa M, Mukai Y, Takahashi Y, Sako K, Toyama H, Inui Y, Taki Y, Nagayama H, Ono K, Kono A, Sekiguchi K, Hirano S, Sato N. Voxel-based analysis of age and gender effects on striatal [(123)I] FP-CIT binding in healthy Japanese adults. Ann Nucl Med. 2022 May;36(5):460-467. IF 2.6
  47. Suzuki Y, Shibuya K, Misawa S, Suichi T, Tsuneyama A, Kojima Y, Nakamura K, Kano H, Prado M, Kuwabara S. Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study. BMC Neurol. 2022 Mar 11;22(1):85. IF 2.6
  48. Takeda T, Kokubun S, Saito Y, Tsuneyama A, Ishikawa A, Isose S, Ito K, Arai K, Koreki A, Sugiyama A, Kuwabara S, Honda K. Progressive medial temporal degeneration with TDP-43 pathology is associated with upper limb and bulbar onset types of amyotrophic lateral sclerosis. J Neurol. 2022 Oct;269(10):5497-5509. IF 6.0
  49. Tanimura Y, Hiroaki Y, Mori M, Fujiyoshi Y. Cell-based flow cytometry assay for simultaneous detection of multiple autoantibodies in a single serum sample. Anal Biochem. 2022 Aug 1;650:114721. IF 2.9
  50. Tohnai G, Nakamura R, Atsuta N, Nakatochi M, Hayashi N, Ito D, Watanabe H, Watanabe H, Katsuno M, Izumi Y, Taniguchi A, Kanai K, Morita M, Kano O, Kuwabara S, Oda M, Abe K, Aoki M, Aiba I, Okamoto K, Mizoguchi K, Ishihara T, Kawata A, Yokota T, Hasegawa K, Nagano I, Yabe I, Tanaka F, Kuru S, Hattori N, Nakashima K, Kaji R, Sobue G, Japanese Consortium for Amyotrophic Lateral Sclerosis R. Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2022 May;113:131-136. IF 4.2
  51. Tsuneyama A, Shibuya K, Misawa S, Suzuki Y, Suichi T, Kojima Y, Nakamura K, Kano H, Mario J.Prado, Kuwabara S. Fatigue and activity-dependent conduction block in neuromuscular disorders. Clin Neurophysiol Pract. 2022 Mar 2;7:71-77. IF 1.7
  52. Watanabe K, Shibuya K, Misawa S, Nagashima K, Suzuki Y, Suichi T, Kojima Y, Nakamura K, Kano H, Prado M, Uzawa A, Kuwabara S. Impaired neuromuscular transmission in facial muscles of amyotrophic lateral sclerosis: A single-fiber electromyography study. Neurology and Clinical Neuroscience. 2022 Mar;10(2):78-82. IF 0.4
  53. Watanabe M, Hiraga A, Kuwabara S. Peripheral-type facial palsy as an initial symptom of lateral medullary infarction. Acta Neurol Belg. 2022 Jun;122(3):851-853. IF 2.7
  54. Yoshikawa H, Adachi Y, Nakamura Y, Kuriyama N, Murai H, Nomura Y, Sakai Y, Iwasa K, Furukawa Y, Kuwabara S, Matsui M. Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan. BMJ Neurol Open. 2022 Sep 5;4(2):e000291. IF 2.7
  55. Yoshikawa H, Adachi Y, Nakamura Y, Kuriyama N, Murai H, Nomura Y, Sakai Y, Iwasa K, Furukawa Y, Kuwabara S, Matsui M. Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018. PLoS One. 2022 Sep 21;17(9):e0274161. IF 3.7

 

2021年（Total Impact Facto 1003.417）総説10件　原書・短報48件

総説

  1. Hirano S. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease. Mol Med. 2021 Apr 15;27(1):40. IF6.382
  2. Kuwabara S, Suichi T, Misawa S. 'Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs' by Marsh et al. J Neurol Neurosurg Psychiatry. 2021;92(2):118-119. IF13.654
  3. Masuda H, Mori M, Kuwabara S. Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1251. IF13.654
  4. Misawa S. Development of new treatments with drug repositioning strategies: POEMS and Guillain Barr? syndrome. Neurol Clin Neurosci. 2021 Jan;9(1):50-55. IF－
  5. Mori M. Insights from the differences in clinical profiles of neuroimmune disorders between patients in Japan and those in Western countries. Clinical and Experimental Neuroimmunology. 2021 Aug;12(3):146-147. IF－
  6. Sawai S, Mori M, Kuwabara S. Methodology for identification of new target molecules in neuroimmunological disorders. Clinical and Experimental Neuroimmunology. 2021 Aug;12(3):202-207. IF－
  7. Uzawa A, Kuwabara S, Suzuki S, Imai T, Murai H, Ozawa Y, Yasuda M, Nagane Y, Utsugisawa K. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol. 2021;203(3):366-374. IF 5.732
  8. Uzawa A, Mori M, Kuwabara S. Different patterns of brainstem and cerebellar MRI abnormalities in demyelinating disorders with MOG and aquaporin-4 antibodies. J Neurol Neurosurg Psychiatry. 2021;92(4)348. IF 13.654
  9. Kohle F, Kuwabara S, Lehmann H C. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review. J Neurol Neurosurg Psychiatry. 2021;92(5):473-478. IF 13.654
  10. Shahrizaila N, Lehmann H C. Kuwabara S. Guillain-Barré syndrome. Lancet.2021 Mar 27;397(10280):1214-1228. IF 202.731

原著・短報

  1. Akamine H, Uzawa A, Kuwabara S. Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis. JAMA Neurol. 2021 Sep 1;78(9):1153. IF 29.907
  2. Aoki R, Mori M, Suzuki Y I, Uzawa A, Masuda H, Uchida T, Ohtani R, Kuwabara S. Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset. Neurol Clin Pract. 2021 Aug;11(4):e549-e550. IF－
  3. Araki N, Yamanaka Y, Poudel A, Fujinuma Y, Katagiri A, Kuwabara S, Asahina M. Electrogastrography for diagnosis of early-stage Parkinson's disease. Parkinsonism Relat Disord. 2021;86:61-66. IF 4.402
  4. Hirano S, Sakakibara R, Komatsu N, Shimizu K, Ishikawa M, Hosoi N, Asahi T, Shuno T, Sugihara H, Kanai S, Miura N, Mochida H, Ozawa Y, Iyo M, Kuwabara S. Characteristics of Early-Onset Dementia in Chiba Prefecture, Japan: A Multicenter Survey. Dement Geriatr Cogn Disord. 2021;50(3):283-288. IF 3.346
  5. Kojima Y, Shibuya K, Uzawa A, Kano H, Nakamura K, Yasuda M, Suzuki Y I, Tsuneyama A, Suichi T, Ozawa Y, Misawa S, Noto Y I, Mizuno T, Kuwabara S. Dispersion of mean consecutive differences in single-fiber electromyography increases diagnostic sensitivity for myasthenia gravis. Muscle Nerve. 2021;63(6):885-889. IF 3.852
  6. Kojima Y, Uzawa A, Ozawa Y, Yasuda M, Onishi Y, Akamine H, Kawaguchi N, Himuro K, Noto Y,Mizuno T, Kuwabara S. Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome. J Neurol Neurosurg Psychiatry. 2021 Sep;92(9):963-968. IF 13.654
  7. Kurumada K, Sugiyama A, Hirano S, Yamamoto T, Yamanaka Y, Araki N, Yakiyama M, Yoshitake M, Kuwabara S. Pareidolia in Parkinson's Disease and Multiple System Atrophy. Parkinsons Dis. 2021 Oct 31;2021:2704755. IF 3.170
  8. Liu J, Mori M, Zimmermann H, Brandt A, Havla J, Tanaka S, Sugimoto K, Oji S, Uzawa A, Asseyer S, Cooper G, Jarius S, Bellmann-Strobl J, Ruprecht K, Siebert N, Masuda H, Uchida T, Ohtani R, Nomura K, Meinl E, Kuempfel T, Paul F, Kuwabara S. Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany. J Neurol Neurosurg Psychiatry. 2021;92(4):377–383. IF 13.654
  9. Liu W, Yamamoto T, Yamanaka Y, Asahina M, Uchiyama T, Hirano S, Shimizu K, Higuchi Y, Kuwabara S. Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation. Front Neurol. 2021;12:656041. IF 4.086
  10. Maimaitiming B, Uzawa A, Ozawa Y, Yasuda M, Kojima Y, Kanai T, Kuwabara S. High mobility group box 1 is involved in the pathogenesis of passive transfer myasthenia gravis model. Neuroreport. 2021;32(9):803-807. IF 1.703
  11. Ozawa Y, Uzawa A, Yasuda M, Kojima Y, Oda F, Himuro K, Kawaguchi N, Kuwabara S. Changes in serum complements and their regulators in generalised myasthenia gravis. Eur J Neurol. 2021;28(1):314-322. IF 6.288
  12. Ozawa Y, Uzawa A, Yasuda M, Kojima Y, Onishi Y, Oda F, Kanai T, Himuro K, Kawaguchi N, Kuwabara S. Long-term outcomes and prognostic factors in generalized myasthenia gravis. J Neurol. 2021 Oct;268(10):3781-3788. IF 6.682
  13. Sawai S, Mori M, Makino T, Nakano Y, Kuwabara S, Kamitsukasa I. Severe orthostatic hypotension associated with lesions of the area postraema in neuromyelitis optica spectrum disorder. eNeurologicalSci. 2021;23:100335. IF－
  14. Shibuya K, Sawai S, Sugiyama A, Koide M, Nishiyama A, Aoki M, Kuwabara S. Facial onset amyotrophic lateral sclerosis with K3E variant in the Cu/Zn superoxide dismutase gene. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(1-2):144-146. IF 3.528
  15. Sugimoto K, Mori M, Liu J, Shibuya K, Isose S, Koide M, Hiwasa T, Kuwabara S. Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):388-394. IF 3.528
  16. Sugiyama A, Onishi Y, Ito K, Shibuya K, Nakamura K, Oda F, Nishino I, Suzuki S, Kuwabara S. Marked Respiratory Failure in an Ambulant Patient with Immune-mediated Necrotizing Myopathy and Anti-Kv1.4 and Anti-titin Antibodies. Intern Med. 2021 Aug 15;60(16):2671-2675. IF 1.282
  17. Sugiyama A, Cooper G, Hirano S, Yokota H, Mori M, Shimizu K, Yakiyama M, Finke C, Brandt A U, Paul F, Kuwabara S. Cognitive Impairment in Multiple System Atrophy Is Related to White Matter Damage Detected by the T1-Weighted/T2-Weighted Ratio. Eur Neurol. 2021;84(6):435-443. IF 2.292
  18. Sugiyama A, Suzuki M, Suichi T, Uchida T, Iizuka T, Tanaka K, Yoneda M, Kuwabara S. Gerstmann's Syndrome in a Patient Double-positive for Antibodies against the N-methyl-D-aspartate Receptor and NH(2)-terminal of α-enolase. Intern Med. 2021;60(9):1463-1468. IF1.282
  19. Sugiyama A, Takeda T, Koide M, Yokota H, Mukai H, Kitayama Y, Shibuya K, Araki N, Ishikawa A, Isose S, Ito K, Honda K, Yamanaka Y, Sano T, Saito Y, Arai K, Kuwabara S. Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case. BMC Neurol. 2021 Jul 9;21(1):273. IF 2.903
  20. Sugiyama A, Yokota H, Hirano S, Cooper G, Mukai H, Koide K, Wang J, Ito S, Finke C, Brandt A U, Paul F, Kuwabara S. Magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle might be a sensitive biomarker for multiple system atrophy. Eur Radiol. 2021;31(6):4277-4284. IF 7.034
  21. Sugiyama A, Yokota H, Misawa S, Mukai H, Sekiguchi Y, Koide K, Suichi T, Matsushima J, Kishimoto T, Tanei Z I, Saito Y, Ito S, Kuwabara S. Cerebral large artery stenosis and occlusion in POEMS syndrome. BMC Neurol. 2021 Jun 24;21(1):239. IF 2.903
  22. Suzuki Y I, Ma Y, Shibuya K, Misawa S, Suichi T, Tsuneyama A, Nakamura K, Matamala J M, Dharmadasa T, Vucic S, Fan D, Kiernan M C , Kuwabara S. Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation. J Neurophysiol. 2021 Sep 1;126(3):840-844. IF 2.974
  23. Uzawa A, Akamine H, Kojima Y, Ozawa Y, Yasuda M, Onishi Y, Sawai S, Kawasaki K, Asano H, Ohyama S, Matsushita K, Mori M, Kuwabara S. High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis. J Neuroimmunol. 2021 Sep 15;358:577634. IF 3.221
  24. Agarwal S, Highton-Williamson E, Caga J, Howells J, Dharmadasa T, Matamala J M, Ma Y, Shibuya K, Hodges J R, Ahmed R M, Vucic S, Kiernan M C. Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis. Sci Rep. 2021;11(1):2172. IF 4.997
  25. Asseyer S, Masuda H, Mori M, Bellmann-Strobl J, Ruprecht K, Siebert N, Cooper G, Chien C, Duchow A, Schließeit J, Liu J, Sugimoto K, Uzawa A, Ohtani R, Paul F, Brandt A U, Kuwabara S, Zimmermann H G. AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin. 2021;7(2):20552173211006862. IF－
  26. Hiraga A, Mori M, Kuwabara S. Dementia and Parkinson-like syndrome with basal ganglia lesion in neuromyelitis optica spectrum disorders. Neurocase. 2021;27(2):223-226. IF 0.781
  27. Hiwasa T, Wang H, Goto K I, Mine S, Machida T, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kunimatsu M, Kamitsukasa I, Mori M, Sugimoto K, Uzawa A, Muto M, Kuwabara S, Kobayashi Y, Ohno M, Nishi E, Hattori A, Yamamoto M, Maezawa Y, Kobayashi K, Ishibashi R, Takemoto M, Yokote K, Takizawa H, Kishimoto T, Matsushita K, Kobayashi S, Nomura F, Arasawa T, Kagaya A, Maruyama T, Matsubara H, Tomiita M, Hamanaka S, Imai Y, Nakagawa T, Kato N, Terada J, Matsumura T, Katsumata Y, Naito A, Tanabe N, Sakao S, Tatsumi K, Ito M, Shiratori F, Sumazaki M, Yajima S, Shimada H, Shirouzu M, Yokoyama S, Kudo T, Doi H, Iwase K, Ashino H, Li S Y, Kubota M, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Iwadate Y. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. BMC Med. 2021;19(1):131. IF 11.806
  28. Kawai T, Sakakibara R, Aiba Y, Tateno F, Ogata T, Sawai S. Increased biological antioxidant potential in the cerebrospinal fluid of transient global amnesia patients. Sci Rep. 2021 Aug 5;11(1):15861. IF 4.997
  29. Kobayashi M, Kuwabara S. The Association of Visually Guided Saccades and DAT-SPECT Findings in Parkinson's Disease. Eur Neurol. 2021;84(2):110-118. IF 2.292
  30. Kristensen A G, Gylfadottir S, Itani M, Kuwabara S, Krøigård T, Khan K S, Finnerup N B, Andersen H, Jensen T S, Sindrup S, Tankisi H. Sensory and motor axonal excitability testing in early diabetic neuropathy. Clin Neurophysiol. 2021;132(7):1407-1415. IF 4.861
  31. Kumutpongpanich T, Ogasawara M, Ozaki A, Ishiura H, Tsuji S, Minami N, Hayashi S, Noguchi S, Iida A, Nishino I, Mori-Yoshimura M, Oya Y, Ono K, Shimizu T, Kawata A, Shimohama S, Toyooka K, Endo K, Toru S, Sasaki O, Isahaya K, Takahashi M. P, Iwasa K, Kira J. I, Yamamoto T, Kawamoto M, Hamano T, Sugie K, Eura N, Shiota T, Koide M, Sekiya K, Kishi H, Hideyama T, Kawai S, Yanagimoto S, Sato H, Arahata H, Murayama S, Saito K, Hara H, Kanda T, Yaguchi H, Imai N, Kawagashira Y, Sanada M, Obara K, Kaido M, Furuta M, Kurashige T, Hara W, Kuzume D, Yamamoto M, Tsugawa J, Kishida H, Ishizuka N, Morimoto K, Tsuji Y, Tsuneyama A, Matsuno A, Sasaki R, Tamakoshi D, Abe E, Yamada S, Uzawa A. Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes. JAMA Neurol. 2021 Jul 1;78(7):853-863. IF 29.907
  32. Lee C, Suzuki Y, Misawa S. Role of plasma exchange for autoimmune autonomic ganglionopathy: A case report. Ther Apher Dial. 2021 Dec;25(6):1016-1017. IF 2.195
  33. Luijten L W G, Leonhard S E, van der Eijk A A, et al IGOS consortium(Kuwabara S). Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain. 2021 Dec 16;144(11):3392-3404. IF 15.255
  34. Mantegazza R, Wolfe G I, Muppidi S, Wiendl H, Fujita K P, O'Brien F L, Booth H D E, Howard J F, Jr. REGAIN Study Group.( Uzawa A, Kanai T, Kawaguchi N, Mori M, Ozawa Y.) Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension. Neurology. 2021 Jan 26;96(4):e610-e618. IF 12.258
  35. Nakamura R, Tohnai G, Atsuta N, Nakatochi M, Hayashi N, Watanabe H, Yokoi D, Watanabe H, Katsuno M, Izumi Y, Taniguchi A, Kanai K, Morita M, Kano O, Kuwabara S, Oda M, Abe K, Aoki M, Aiba I, Okamoto K, Mizoguchi K, Hattori N, Nakashima K, Kaji R Sobue G. Genetic and functional analysis of KIF5A variants in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2021;97:147.e11-147.e17. IF 5.133
  36. Nishimura K,  Iwai Y,  Yabuki M, Fuse H, Nakamichi K, Takahashi K, Suzuki T, Saijo M, Fukushima T, Kuwabara S. Lenalidomide-associated progressive multifocal leukoencephalopathy. Clinical and Experimental Neuroimmunology. 2021;12:63–65. IF－
  37. Otte K, Ellermeyer T, Suzuki M, Röhling H M, Kuroiwa R, Cooper G, Mansow-Model S, Mori M, Zimmermann H, Brandt A U, Paul F, Hirano S, Kuwabara S, Schmitz-Hübsch T. Cultural bias in motor function patterns: Potential relevance for predictive, preventive, and personalized medicine. Epma j. 2021;12(1):91-101. IF 8.836
  38. Sakurai T, Hirano S, Abe M, Uji Y, Shimizu K, Suzuki M, Nakano Y, Ishikawa A, Kojima K, Shibuya K, Murata A, Kuwabara S. Dysfunction of the left angular gyrus may be associated with writing errors in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(3-4):267-275. IF 3.528
  39. Shibamiya A, Ohwada C, Ishii A, Mishina T, Nagai Y, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Tsukamoto S, Takeda Y, Mitsukawa S, Mimura N, Iseki T, Misawa S, Kuwabara S, Nakaseko C, Sakaida E. Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome. Bone Marrow Transplant. 2021;56(2):517-520. IF 5.174
  40. Shikino K, Sato R, Hanazawa N, Yasuda M, Ikusaka M. Chronic clicking tinnitus due to palatal tremor: essential or secondary? Lancet. 2021 Jun 19;397(10292):e16. IF 202.731
  41. Shimizu S, Iijima M, Fukami Y, Tamura N, Nakatochi M, Ando M, Nishi R, Koike H, Kaida K, Koga M, Kanda T, Ogata H, Kira J I, Mori M, Kuwabara S, Katsuno M. Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial. JMIR Res Protoc. 2020;9(4):e17117. IF－
  42. Van den Bergh P Y K, van Doorn P A, Hadden R D M, Avau B, Vankrunkelsven P, Allen J A, Attarian S, Blomkwist P H, Cornblath D R, Eftimov F, Goedee H S, Harbo T, Kuwabara S, Lewis R A, Lunn M P, Nobile-Orazio E, Querol L, Rajabally Y A, Sommer C, Topaloglu H A. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force - Second Revision. J Peripher Nerv Syst. 2021 Sep;26(3):242-268. IF 5.188
  43. Van den Bergh P Y K, van Doorn P A, Hadden R D M, Avau B, Vankrunkelsven P, Allen J A, Attarian S, Blomkwist-Markens P H, Cornblath D R, Eftimov F, Goedee H S, Harbo T, Kuwabara S, Lewis R A, Lunn M P, Nobile-Orazio E, Querol L, Rajabally Y A, Sommer C, Topaloglu H A. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021 Nov;28(11):3556-3583. IF 6.288
  44. Verboon C, Harbo T, Cornblath D R, Hughes R A C, van Doorn P A, Lunn M P, Gorson K C, Barroso F, Kuwabara S, Galassi G, Lehmann H C, Kusunoki S, Reisin R C, Binda D, Cavaletti G, Jacobs B C. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1080-1088. IF13.654
  45. Wingerchuk D M, Fujihara K, Palace J, Berthele A, Levy M, Kim H J, Nakashima I, Oreja-Guevara C, Wang K C, Miller L, Shang S, Sabatella G, Yountz M, Pittock S J, PREVENT Study Group.(Mori M, Otani R,  Sekiguchi Y, Shibuya K, Uzawa A.) Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Ann Neurol. 2021 Jun;89(6):1088-1098. IF 11.274
  46. Yakufujiang M, Higuchi Y, Aoyagi K, Yamamoto T, Sakurai T, Abe M, Okahara Y, Izumi M, Nagano O, Yamanaka Y, Hirano S, Shiina A, Murata A, Iwadate Y. Predicting Neurocognitive Change after Bilateral Deep Brain Stimulation of Subthalamic Nucleus for Parkinson's Disease. World Neurosurg. 2021 Mar;147:e428-e436. IF2.210
  47. Yamamoto Y, Matsui N, Uzawa A, Ozawa Y, Kanai T, Oda F, Kondo H, Ohigashi I, Takizawa H, Kondo K, Sugano M, Kitaichi T, Hata H, Kaji R, Kuwabara S, Yamamura T, Izumi Y. Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease. Neurology-Neuroimmunology & Neuroinflammation. 2021 Sep 24;8(6):e1087. IF11.360
  48. Yoshii S, Shibuya K, Yokota H, Ikehara H, Shiohama T, Sawada D, Kuwabara S, Fujii K. Magnetic resonance neurography in diagnosing childhood chronic inflammatory demyelinating polyradiculoneuropathy. Brain Dev.2021;43(2):352-356. IF2.272